Treatment of alopecia areata with the 308-nm xenon chloride excimer laser: case report of two successful treatments with the excimer laser.

Abstract

BACKGROUND AND OBJECTIVES:

Alopecia areata is a common disease of unknown etiology; it causes significant cosmetic and psycho-social distress for most of the people it affects. We report on an innovative form of treatment in two patients with typical alopecia areata on the capillitium.

STUDY DESIGN/PATIENTS AND METHODS:

We successfully treated two patients whose alopecia areata had worsened progressively for 3 and 14 weeks. The treatment involved the use of a 308 nm xenon chloride excimer laser (dosage 300-2,300 mJ/cm(2) per session).

RESULTS:

After 11 and 12 sessions within a 9-week and 11-week period, the entire affected focus showed homogenous and thick regrowth. No relapse was observed during the follow-up period of 5 and 18 months.

CONCLUSIONS:

The use of the excimer laser is an effective, elegant, and safe means of treatment and has good tolerability. Analogous to topical treatment of alopecia areata, the immunosuppressive mechanism of the excimer laser can be interpreted as an induction of T-cell apoptosis. This new means of treatment has yet to be discussed in medical literature. Further studies with greater numbers are needed to assess its potential more precisely and evaluate the excimer laser in treating alopecia areata.

• Authors: Cuneyt Gundogan, Bärbel Greve, Christian Raulin
• Journal: Lasers in surgery and medicine (Lasers Surg Med) Vol. 34 Issue 2 Pg. 86-90 ( 2004) ISSN: 0196-8092 [Print] United States
• PMID: 15004817 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright 2004 Wiley-Liss, Inc.

Chemical References

• Chlorides
• Xenon
• xenon chloride

Topics

• Adult
• Alopecia Areata (radiotherapy)
• Chlorides
• Female
• Humans
• Laser Therapy
• Male
• Middle Aged
• Radiotherapy Dosage
• Time Factors
• Treatment Outcome
• Xenon